Expert insights on Pharma innovation, Biotech strategy and Medtech breakthroughs for life sciences professionals.
Our editorial framework examines what's happening now, why it matters and what to look for next across pharma, biotech and medtech.
Grateful to our Industry Intelligence partners whose insights and expertise shaped this section of the issue.
Overcoming Barriers to Subcutaneous
Delivery
Nucleic acid therapeutics span multiple complex modalities with very different stability profiles. Early formulation decisions set the limits of scale and viability. Without the right analytical depth, risks remain hidden until later stages.
Transmucosal delivery can bypass first-pass metabolism and enable rapid onset. It offers a practical route for molecules that struggle with oral delivery. The challenge is identifying suitability early using clear physicochemical criteria.
